Legato Capital Management’s Astera Labs ALAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$416K Sell
3,793
-3,254
-46% -$463K 0.04% 566
2025
Q4
$1.17M Buy
7,047
+982
+16% +$164K 0.1% 315
2025
Q3
$1.19M Sell
6,065
-4,743
-44% -$780K 0.13% 246
2025
Q2
$977K Buy
10,808
+5,691
+111% +$450K 0.12% 279
2025
Q1
$305K Sell
5,117
-20,495
-80% -$1.9M 0.04% 486
2024
Q4
$3.39M Buy
25,612
+10,386
+68% +$975K 0.44% 31
2024
Q3
$798K Buy
15,226
+11,801
+345% +$554K 0.1% 357
2024
Q2
$207K Buy
+3,425
New +$238K 0.03% 519

Other funds holding ALAB

Legato Capital Management's ALAB Position: Q1 2026 in Review

Legato Capital Management reduced its Astera Labs (ALAB) stake by 46% in Q1 2026, selling an estimated $463K and leaving 3,793 shares worth $416K. The position accounts for 0.04% of the portfolio, ranked #566.

Legato Capital Management first reported a position in ALAB in Q2 2024 and has held it in 8 quarters since. The position peaked at $3.39M in Q4 2024. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Legato Capital Management held 3,793 shares of Astera Labs worth $416K as of Q1 2026.
  • Legato Capital Management sold 3,254 Astera Labs shares in Q1 2026, an estimated $463K.
  • Astera Labs made up 0.04% of Legato Capital Management's portfolio in Q1 2026, its #566 holding.
  • Legato Capital Management first reported a position in Astera Labs in Q2 2024 and has held it in 8 quarters since.
  • Legato Capital Management's Astera Labs position peaked at $3.39M in Q4 2024.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Legato Capital Management's 13F filing for Q1 2026, filed 14 May 2026.